Top Markets
#1 Islamic Coin Islamic Coin +155.99%
#2 Siren Siren +37.65%
#3 Venom Venom +24.83%
#4 Arowana Arowana +21.47%
#5 RedStone RedStone +16.63%
#6 Verus Coin Verus Coin +15.10%
#7 OpenEden OpenEden +13.79%
#8 Nockchain Nockchain +13.72%
#9 KUB Coin KUB Coin +13.52%
#10 Perle Perle +12.30%
Coin of the day
Islamic Coin Islamic Coin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
PCL, Inc. PCL, Inc.

PCL, Inc.

241820
Rang in Aktien #31786
PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic... PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.
Aktienkurs
$0.21291741
Zuletzt synchronisiert: 2025-04-18
Marktkapitalisierung
$12.07M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
KR
Handel PCL, Inc. (241820)

Kategorie

Healthcare
Anzahl der ausstehenden Aktien von PCL, Inc. (241820)
Anzahl der ausstehenden Aktien zum September 2025: 2.78M
Laut den neuesten Finanzberichten und dem Aktienkurs von PCL, Inc. beträgt die aktuelle Anzahl der ausstehenden Aktien 2.78M. Am Ende von December 2023 hatte das Unternehmen 40.62M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von PCL, Inc. (241820) von 2015 bis 2026
Ausstehende Aktien am Ende jedes Jahres
Jahr Ausstehende Aktien ändert
2026 (TTM) 2.78M -95.05%
2024 56.15M 38.25%
2023 40.62M 14.64%
2022 35.43M 4.04%
2021 34.05M 5.39%
2020 32.31M 6.30%
2019 30.40M 1.18%
2018 30.04M 2.72%
2017 29.25M -2.51%
2016 30.00M 0.00%
2015 30.00M 0.00%
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
Unternehmen Ausstehende Aktien Unterschied Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 1.74B 62,552.16%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 383.50M 13,684.52%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 1.28B 45,983.78%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 1.48B 53,010.83%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 576.40M 20,618.11%
US